Nystatine

A potent polyene macrolide antibiotic produced through proprietary fermentation using our high-yield Streptomyces noursei strain. Nystatin demonstrates broad antifungal activity, particularly effective against Candida albicans, the leading cause of mucocutaneous and gastrointestinal mycoses. It is a trusted solution for infections of the skin, oral cavity, vagina and GI tract. With a long-standing safety record since its discovery in 1950, Nystatin is characterized by: No observed drug interactions or allergic reactions Minimal systemic absorption Low toxicity and excellent tolerability Due to its favorable safety profile, it is commonly used prophylactically in immunocompromised populations, including patients with HIV/AIDS, those undergoing chemotherapy, individuals on immunosuppressants and diabetic patients. Ideal for pharmaceutical formulations such as oral suspensions, creams, ointments, and vaginal tablets, Nystatin remains a cornerstone antifungal agent for both preventive and therapeutic use.